A machine learning evolutionary algorithm-based formula to assess tumor markers and predict lung cancer in cytologically negative pleural effusions
- 5 Downloads
Malignant pleural effusion is diagnostically challenging in presence of negative cytology. The assessment of tumor markers in serum has become a standard tool in cancer diagnosis, while pleural fluid sampling has not met universal consensus. The evaluation of a panel of markers both in serum and pleural fluid may be crucial to improve the diagnostic accuracy. Using a machine learning-based approach, we provide a mathematical formula capable to express the complex relation existing among the expressed markers in serum and pleural effusion and the presence of lung cancer. The formula indicates CEA and CYFRA21-1 in pleural fluid as the best diagnostic markers, with 97% accuracy, 98% sensitivity, 95% specificity, 96% area under curve, 98% positive predictive value, and 92% MCC (Matthews correlation coefficient).
KeywordsMachine learning Genetic programming Genetic algorithm Evolutionary algorithm Pleural effusion Biochemical tumor marker Thoracentesis Thoracoscopy Video-assisted thoracic surgery
- CA 15-3
Carbohydrate antigen 15-3
Carbohydrate antigen 19-9
- CA 125
Carbohydrate antigen 125
- CYFRA 21-1
Cytocheratin fragment 21-1
GD, AD and SE conceived the study and wrote the paper. RM, RS and CC provided data of tumor marker concentrations. AD performed the tumor markers assay. RS and SE performed the statistical analysis, and the feature selection. GD conceived and implemented the classifier based on the genetic programming. Moreover, GD carried out all the genetic programming-based experiments, and conceived the final formula. GD, FP, AD and SE contributed in the interpretation of the meaning of results, and in writing the Discussion and Conclusion sections. GH and FP revised the final draft of manuscript before submission.
This study was partially funded by Italian Ministry of Education, University and Research as a National Interest Research Project (PRIN) No. 20083YAR35 granted to the University of Rome Tor Vergata.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Furthermore, the study design was carried out according to the protocol “Tumor marker in pleural effusion and biopsies” approved by the ethical committee of Fondazione PTV Policlinico Tor Vergata, Rome, Italy, on November 6, 2018 (authorization Nr.171/18), and all patients gave their informed consent.
- Bennett R, Maskell N (2005) Management of malignant pleural effusions. Curr Opin Pulm Med 11(4):296–300Google Scholar
- Cedrés S, Nuñez I, Longo M, Martinez P, Checa E, Torrejón D, Felip E (2011) Serum tumor markers cea, cyfra21-1, and ca-125 are associated with worse prognosis in advanced non-small-cell lung cancer (nsclc). Clinical Lung Cancer 12(3):172–179. https://doi.org/10.1016/j.cllc.2011.03.019 CrossRefGoogle Scholar
- D’Angelo G, Tipaldi M, Glielmo L, Rampone S (2017) Spacecraft autonomy modeled via markov decision process and associative rule-based machine learning. In: 2017 IEEE international workshop on metrology for aerospace (MetroAeroSpace), pp 324–329. https://doi.org/10.1109/MetroAeroSpace.2017.7999589
- Gu Y, Qiao X, Wang L, Fu X (2017) The diagnostic value of parallel detection of cytokeratin 19 fragment-based tumor markers in malignant pleural effusion: a systematic review and meta-analysis. Biomed Res (India) 28(18):8105–8114Google Scholar
- Gwiazda TD (2006) Crossover for single-objective numerical optimization problems. Tomasz Gwiazda. http://www.tomaszgwiazda.com/Genetic_algorithms_reference_first_40_pages.pdf. Accessed 12 Sept 2019
- Holdenrieder S, Wehnl B, Hettwer K, Simon K, Uhlig S, Dayyani F (2017) Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis. Br J Cancer 116(8):1037–1045. https://doi.org/10.1038/bjc.2017.45 CrossRefGoogle Scholar
- Kohavi R (1995) A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Proceedings of the 14th international joint conference on artificial intelligence. vol 2, IJCAI’95, pp 1137–1143. Morgan Kaufmann Publishers Inc., San Francisco, CA, USA. http://dl.acm.org/citation.cfm?id=1643031.1643047. Accessed 12 Sept 2019
- Korczynski P, Krenke R, Safianowska A, Gorska K, Abou Chaz MB, Maskey-Warzechowska M, Kondracka A, Nasilowski J, Chazan R (2009) Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions. Eur J Med Res 14(Suppl 4):128–133. https://doi.org/10.1186/2047-783x-14-s4-128 CrossRefGoogle Scholar
- Shamsaei B, Gao C (2016) Comparison of some machine learning and statistical algorithms for classification and prediction of human cancer type. In: 2016 IEEE-EMBS international conference on biomedical and health informatics (BHI), pp 296–299. https://doi.org/10.1109/BHI.2016.7455893
- Sharma SK, Bhat S, Chandel V, Sharma M, Sharma P, Gupta S, Sharma S, Bhat AA (2015) Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer. J Carcinog 14:7. https://doi.org/10.4103/1477-3163.170662 CrossRefGoogle Scholar
- Topolcan O, Holubec L, Polivkova V, Svobodova S, Pesek M, Treska V, Safranek J, Hajek T, Bartunek L, Rousarova M, Finek J (2007) Tumor markers in pleural effusions. Anticancer Res. 27(4A):1921–1924Google Scholar
- Trape J, Sant F, Franquesa J, Montesinos J, Arnau A, Sala M, Bernadich O, Martin E, Perich D, Perez C, Lopez J, Ros S, Esteve E, Perez R, Aligue J, Gurt G, Catot S, Domenech M, Bosch J, Badal JM, Bonet M, Molina R, Ordeig J (2017) Evaluation of two strategies for the interpretation of tumour markers in pleural effusions. Respir Res 18(1):103. https://doi.org/10.1186/s12931-017-0582-1 CrossRefGoogle Scholar